Titlebook: Essential Tuberculosis; Giovanni Battista Migliori,Mario C. Raviglione Textbook 2021 Springer Nature Switzerland AG 2021 MDR-TB and drug r

高調(diào)

Tuberculosis Vaccinesording to the World Health Organization and approximately 10 million new cases of disease. Since 1921, the vaccine bacille Calmette-Guérin (BCG) has provided partial and variable protection against TB disease. The last 20?years have seen renewed efforts to develop improved, deployable and affordable

Talkative

Latent Tuberculosis Infection Diagnosis and Treatmentable immunological diagnostic tests, as well as LTBI treatment, referring to the best available evidence and international guidance. It then reviews the evidence for use of LTBI testing and treatment in different settings and populations and discusses the trade-offs between an individual risk-based

云狀

faultfinder

Tuberculosis Clinical Presentation and Differential Diagnosison symptoms and signs of active TB in the lung and extra-pulmonary sites. The sites of disease explored include: pulmonary infections, lymph node disease and central nervous system disease amongst others. Possible differential diagnoses to be considered are discussed within each organ, though often

CAGE

無(wú)王時(shí)期,

Rationale for Anti-Tuberculosis Chemotherapyi, and the probability they have to develop resistance to the anti-TB drugs. The bactericidal and sterilizing activity of the available anti-TB drugs is also presented, to define the minimum requirements for an anti-TB regimen and to shed light on the possible future of anti-TB regimens..In the futu

CRP743